AIM

#4751
AIM ImmunoTech Inc. Common Stock
0.3 9 USD
-7.14%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.39
0.39
Intervallo Annuale
0.21
20.35
Variazione giornaliera
-7.14%
Variazione Mensile
-23.54%
Variazione di 6 mesi
-75.65%
Variazione Annuale
-95.41%
Chiusura Precedente
0.4 2
Open
0.3 9
Minimo
0.3 9
High
0.3 9
Volume
233
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

AIM ImmunoTech Inc. Common Stock

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Notizie